Boehringer Ingelheim supports victims of typhoon Haiyan in the Philippines

Ingelheim, 12 November 2013 – Boehringer Ingelheim is donating €250,000 for the victims of the devastating typhoon Haiyan in the Philippines. The sum will be provided to the German Red Cross as emergency aid. In addition, the Philippine subsidiary of Boehringer Ingelheim is supporting various aid organisations locally with monetary and medicine donations.
“With our donation, we want to make a contribution to helping the people affected by this terrible natural disaster and their families as quickly as possible,” emphasised Prof. Dr Andreas Barner, Chairman of the Board of Managing Directors of Boehringer Ingelheim.

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.

For more information please visit www.boehringer-ingelheim.com.